NASDAQ | Warrant
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting.
The company develops three-dimensional (3D)-vector electrocardiogram (ECG) platform for heart attack detection.
It is developing HeartBeam AIMI software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack; and HeartBeam AIMIGo, a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection.
The company was incorporated in 2015 and is based in Santa Clara, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 30, 21 | -0.26 Decreased by -306.04% | - |
| Mar 31, 21 | -0.06 Decreased by -19.25% | - |
| Dec 31, 20 | -0.09 | - |
| Sep 30, 20 | -0.09 | - |
| Jun 30, 20 | -0.06 | - |
| Mar 31, 20 | -0.05 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | -3.47 M Increased by +1.42% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -3.15 M Increased by +10.01% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -4.12 M Decreased by -92.16% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -3.66 M Decreased by -75.44% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -3.52 M Decreased by -196.30% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -3.50 M Decreased by -270.90% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -2.14 M Decreased by -920.00% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -2.08 M Decreased by -529.91% | Decreased by N/A% Decreased by N/A% |